Found: 197
Select item for more details and to access through your institution.
Virulence determinants of pandemic influenza viruses.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Berichtigung: Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 31, p. 16878, doi. 10.1002/ange.202105635
- By:
- Publication type:
- Article
Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 17, p. 9553, doi. 10.1002/ange.202015362
- By:
- Publication type:
- Article
Current Status of COVID‐19 (Pre)Clinical Vaccine Development.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 43, p. 19045, doi. 10.1002/ange.202008319
- By:
- Publication type:
- Article
Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01780-8
- By:
- Publication type:
- Article
Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99431-5
- By:
- Publication type:
- Article
Evasion of innate and adaptive immune responses by influenza A virus.
- Published in:
- Cellular Microbiology, 2010, v. 12, n. 7, p. 873, doi. 10.1111/j.1462-5822.2010.01475.x
- By:
- Publication type:
- Article
Genetically engineered Newcastle disease virus for malignant melanoma therapy.
- Published in:
- Gene Therapy, 2009, v. 16, n. 6, p. 796, doi. 10.1038/gt.2009.14
- By:
- Publication type:
- Article
Influenza virus mRNAs encode determinants for nuclear export via the cellular TREX-2 complex.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37911-0
- By:
- Publication type:
- Article
SARS-CoV-2 Inhibitors Identified by Phenotypic Analysis of a Collection of Viral RNA-Binding Molecules.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 12, p. 1448, doi. 10.3390/ph15121448
- By:
- Publication type:
- Article
Reflexiones para la introducción de Colaboración y Gamificación en MOOC.
- Published in:
- Revista Latinoamericana de Tecnología Educativa, 2019, v. 18, n. 1, p. 163, doi. 10.17398/1695-288X.18.1.163
- By:
- Publication type:
- Article
The makings of a killer.
- Published in:
- Nature Medicine, 2002, v. 8, n. 9, p. 927, doi. 10.1038/nm0902-927
- By:
- Publication type:
- Article
Generation of antigen-specific memory CD4 T cells by heterologous immunization enhances the magnitude of the germinal center response upon influenza infection.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 9, p. 1, doi. 10.1371/journal.ppat.1011639
- By:
- Publication type:
- Article
Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 1, p. 1, doi. 10.1371/journal.ppat.1011805
- By:
- Publication type:
- Article
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 3, p. 1255, doi. 10.1172/JCI74374
- By:
- Publication type:
- Article
Cross-presenting CD103+ dendritic cells are protected from influenza virus infection.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Cross-presenting CD103<sup>+</sup> dendritic cells are protected from influenza virus infection.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 11, p. 4037, doi. 10.1172/JCI60659
- By:
- Publication type:
- Article
Genomic and ultrastructural analysis of monkeypox virus in skin lesions and in human/animal infected cells reveals further morphofunctional insights into viral pathogenicity.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 6, p. 1, doi. 10.1002/jmv.28878
- By:
- Publication type:
- Article
ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon.
- Published in:
- EMBO Reports, 2013, v. 14, n. 9, p. 780, doi. 10.1038/embor.2013.102
- By:
- Publication type:
- Article
Evolution of influenza A virus in intensive and free-range swine farms in Spain.
- Published in:
- Virus Evolution, 2021, v. 7, n. 2, p. 1, doi. 10.1093/ve/veab099
- By:
- Publication type:
- Article
Engineering Non-Human RNA Viruses for Cancer Therapy.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1617, doi. 10.3390/vaccines11101617
- By:
- Publication type:
- Article
Development of a Macrophage-Based ADCC Assay.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 660, doi. 10.3390/vaccines9060660
- By:
- Publication type:
- Article
Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.
- Published in:
- Vaccines, 2021, v. 9, n. 1, p. 40, doi. 10.3390/vaccines9010040
- By:
- Publication type:
- Article
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 771, doi. 10.3390/vaccines8040771
- By:
- Publication type:
- Article
Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 666, doi. 10.3390/vaccines8040666
- By:
- Publication type:
- Article
TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 113, doi. 10.3390/vaccines7030113
- By:
- Publication type:
- Article
Moving from Empirical to Rational Vaccine Design in the 'Omics' Era.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 89, doi. 10.3390/vaccines7030089
- By:
- Publication type:
- Article
A HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model.
- Published in:
- Vaccines, 2019, v. 7, n. 2, p. 41, doi. 10.3390/vaccines7020041
- By:
- Publication type:
- Article
Erratum: Sunwoo, S.-Y. et al. A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies. Vaccines 2018, 6(3), 64.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies.
- Published in:
- Vaccines, 2018, v. 6, n. 3, p. 64, doi. 10.3390/vaccines6030064
- By:
- Publication type:
- Article
Origins of the 2009 H1N1 influenza pandemic in swine in Mexico.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.16777
- By:
- Publication type:
- Article
ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.10859
- By:
- Publication type:
- Article
An intranasal recombinant NDV-BRSV F<sub>opt</sub> vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-26938-w
- By:
- Publication type:
- Article
Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.791764
- By:
- Publication type:
- Article
Antiviral Response in Pandemic Influenza Viruses.
- Published in:
- Emerging Infectious Diseases, 2006, v. 12, n. 1, p. 44, doi. 10.3201/eid1201.051186
- By:
- Publication type:
- Article
A Novel Paramyxovirus?
- Published in:
- Emerging Infectious Diseases, 2005, v. 11, n. 1, p. 108, doi. 10.3201/eid1101.040653
- By:
- Publication type:
- Article
New Data on Influenza Virus Type C Confirm Its Peculiarities as a New Genus.
- Published in:
- Intervirology, 1991, v. 32, n. 6, p. 325, doi. 10.1159/000150216
- By:
- Publication type:
- Article
Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
- Published in:
- International Immunology, 1997, v. 9, n. 11, p. 1641, doi. 10.1093/intimm/9.11.1641
- By:
- Publication type:
- Article
BioHealthBase: informatics support in the elucidation of influenza virus host–pathogen interactions and virulence.
- Published in:
- Nucleic Acids Research, 2008, v. 36, p. D497, doi. 10.1093/nar/gkm905
- By:
- Publication type:
- Article
Immunological imprinting of the antibody response in COVID-19 patients.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23977-1
- By:
- Publication type:
- Article
SARS-CoV-2 Neutralizing Antibodies in Free-Ranging Fallow Deer (Dama dama) and Red Deer (Cervus elaphus) in Suburban and Rural Areas in Spain.
- Published in:
- Transboundary & Emerging Diseases, 2023, p. 1, doi. 10.1155/2023/3324790
- By:
- Publication type:
- Article
MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 9, p. 844, doi. 10.1038/nbt.2666
- By:
- Publication type:
- Article
Attacking the flu: New prospects for the rational design of antivirals.
- Published in:
- Nature Medicine, 2009, v. 15, n. 11, p. 1253, doi. 10.1038/nm1109-1253
- By:
- Publication type:
- Article
Type I Interferon Induction Pathway, but Not Released Interferon, Participates in the Maturation of Dendritic Cells Induced by Negative-Strand RNA Viruses.
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 7, p. 1126
- By:
- Publication type:
- Article
Development of Novel Influenza Virus Vaccines and Vectors.
- Published in:
- Journal of Infectious Diseases, 1997, v. 176, n. Supplement_1, p. S45
- By:
- Publication type:
- Article
P2-298: The novel strategy for generation of effective and safe Alzheimer's disease vaccine based on conventional influenza virus vaccine modified to express Aβ<sub>1-11</sub>
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Regulation of PURA gene transcription by three promoters generating distinctly spliced 5-prime leaders: a novel means of fine control over tissue specificity and viral signals.
- Published in:
- BMC Molecular Biology, 2010, v. 11, p. 81, doi. 10.1186/1471-2199-11-81
- By:
- Publication type:
- Article
Fortalecimiento de las competencias psicoterapéuticas por las enfermeras especialistas en salud mental.
- Published in:
- Metas de Enfermería, 2021, v. 24, n. 4, p. 77
- By:
- Publication type:
- Article
Author Correction: Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus.
- Published in:
- NPJ Vaccines, 2017, v. 2, n. 1, p. N.PAG, doi. 10.1038/s41541-017-0034-4
- By:
- Publication type:
- Article